| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $19.63B | $14.73B | $11.45B |
| YoY Revenue Growth % | +33.2% | +28.6% | — |
| Gross Profit | $10.24B | $7.21B | — |
| Gross Margin % | 52.2% | 48.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.99B | $662.2M | $224.8M |
| Operating Margin % | 10.1% | 4.5% | 2.0% |
| Net Income (GAAP) | $1.58B | $444.3M | $150.7M |
| EBITDA (Normalized) | $2.40B | $916.7M | $637.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.02B | $3.28B | $2.08B |
| Capital Expenditures (CapEx) | $513.8M | $318.2M | $515.4M |
| Free Cash Flow (FCF) | $4.51B | $2.96B | $1.56B |
| FCF Margin % | 23.0% | 20.1% | 13.7% |
| Return on Invested Capital (ROIC %) | 9.9% | 4.2% | 1.1% |
| Cash & Short-Term Equivalents | $4.16B | $2.41B | — |
| Total Debt (Short + Long Term) | $7.53B | $6.37B | $6.03B |
| Total Stockholders' Equity | $12.53B | $8.37B | $12.38B |